Canntab Therapeutics Limited Stock Canadian Securities Exchange

Stocks

24-04-14

23-09-18	Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order	NE
22-08-02	CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO	PR
22-05-30	CANNTAB ANNOUNCES CHANGE OF AUDITOR	PR
22-03-23	CANNTAB SIGNS AFFILIATE AGRREMENT WITH ONPHARM-UNITED	PR
22-01-20	CANNTAB OFFICIALLY LAUNCHES ITS ONLINE E-COMMERCE PLATFORM	PR

Manager	Title	Age	Since
Joshi Laxminarayan CTO	Chief Tech/Sci/R&D Officer	-	2020-05-14
Frank Candido IRC	Investor Relations Contact	61	2018-08-31
Eric Malinski SAM	Sales & Marketing	-	2018-04-30

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CANNTAB THERAPEUTICS LIMITED	-.--%	-.--%	-	-	38
YUNNAN BAIYAO GROUP CO.,LTD	+0.86%	+1.55%	-11.67%	-4.90%	12.94B
BEIJING TONGRENTANG CO., LTD	+1.50%	+0.68%	-33.62%	-55.63%	4.79B
DONG-E-E-JIAO CO., LTD.	+0.96%	+3.80%	-7.08%	-2.70%	4.49B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+0.30%	+5.58%	+23.58%	-1.26%	3.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	+1.15%	+1.67%	+5.33%	-37.13%	3.89B
TASLY PHARMACEUTICAL GROUP CO., LTD	+3.07%	+5.48%	-9.42%	+6.42%	3.17B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	+3.78%	-11.63%	-10.45%	-14.58%	3.16B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+1.63%	+2.24%	-6.44%	-22.75%	2.41B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+2.80%	+7.03%	-9.40%	+39.83%	1.77B
Average	+1.60%	+6.12%	-6.57%	-10.30%	4.5B
Weighted average by Cap.	+1.45%	+5.31%	-8.03%	-12.37%